Newton has launched Newton Preferred, a membership program for independent eye care practices that combines Neurolens technology, eyewear, financing options, and financial incentives in one offering.
According to the company, the program is designed to simplify the adoption and dispensing of Neurolens while providing practices with tools to differentiate their services and support business growth.
“Independent practices are competing in a market that is changing fast, and great service alone no longer sets them apart,” says Davis Corley, CEO of Newton. “Neurolens gives them something the chains can’t copy, and with Newton Preferred, it has never been easier to bring Neurolens into a practice.”
Technology and Practice Benefits
Newton Preferred revolves around Neurolens, a lens technology is designed to address ocular misalignment. Participating practices receive access to several benefits, including:
- Tech financing. Members receive exclusive 0% financing on the Neurolens N3 headset and access to its full software platform.
- Quarterly rebates. Practices can earn volume-based Neurolens rebates intended to offset program costs.
- Preferred lens pricing. Members receive preferred pricing on Sequel lenses, another Newton lens technology designed for patients experiencing digital eye strain.
- Frame offerings. The program includes Newton&co., an exclusive frame collection curated by Newton and supplied by Founders Optical, with frames included with every patient prescription.
- Patient financing. Newton Pay, offered through Cherry, allows patients to finance purchases through monthly payments.
Enrollment and Availability
Practices interested in the program can learn more and connect with a Newton representative for additional details at https://www.newton.tech/preferred. Pre-sale enrollment for Newton Preferred is now open, with program benefits beginning Dec. 1, 2026, for practices joining through the purchase of the N3 platform. Current Neurolens providers can also enroll beginning Dec. 1. Early access enrollment closes Dec. 31, 2026.
Newton is a Dallas-based eye care technology company. Its suite of lenses includes Neurolens, with its patented Contoured Prism technology, and Sequel, with proprietary Convergence Boost technology.